title: [Seroepidemiologic study of rubella in childbearing women in Aragon, Spain (2003-2007)].
abstract: OBJECTIVE
  To quantify and identify the rubella-susceptible population in Aragon according to sociodemographic variables, with the aim of assessing compliance with the 5% limit set by the World Health Organization (WHO).
  
  
  METHODS
  Rubella serology tests performed in women of childbearing age in the Miguel Servet Hospital from 2003 to 2007 were studied. A descriptive analysis of seronegativity was performed by age, years of study, and WHO region (for 2007). A logistic regression was performed with the independent variables of age and geographical origin.
  
  
  RESULTS
  We studied 13,136 women. The mean age was 31.2 years. During the study period, 5% were susceptible to rubella (95%CI: 4.63-5.37). In 2003, 8.8% were seronegative and the highest percentage (12.3%) was found in women aged 15 to 19 years. The percentage of seronegativity was higher in foreign-born women (7.7%), especially those from Asia, than in Spanish women (3.3%; p<0.05).
  
  
  CONCLUSIONS
  Postpartum preventive strategies should be established to prevent possible rubella outbreaks and cases of congenital rubella syndrome.
authors.affiliation: Unidad Docente de Medicina Preventiva y Salud Pública de Aragón, Zaragoza, España. rhernandezd@aragon.es
authors.forename: Rogelio
authors.initials: R
authors.lastname: Hernández Díaz
authors.forename: María Pilar
authors.initials: MP
authors.lastname: Rodrigo Val
authors.forename: Antonio
authors.initials: A
authors.lastname: Misiego Peral
authors.forename: María Lourdes
authors.initials: ML
authors.lastname: Roc Alfaro
authors.forename: María Begoña
authors.initials: MB
authors.lastname: Adiego Sancho
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000462:Algeria / Q000208:ethnology; D000914:Antibodies, Viral / Q000097:blood*; D002681:China / Q000208:ethnology; D004198:Disease Susceptibility; D054242:Emigrants and Immigrants / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007843:Latin America / Q000208:ethnology; D008875:Middle Aged; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D012383:Romania / Q000208:ethnology; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000276:immunology; D012412:Rubella virus / Q000276:immunology*; D016036:Seroepidemiologic Studies; D013030:Spain / Q000453:epidemiology; D014611:Vaccination / Q000706:statistics & numerical data; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D012411:Rubella Vaccine